Click for best price
Next Generation Cancer Diagnostic Devices Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Next Generation Cancer Diagnostic Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Cancer Diagnostic Devices. This report contains market size and forecasts of Next Generation Cancer Diagnostic Devices in global, including the following market information:
Global Next Generation Cancer Diagnostic Devices Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Next Generation Cancer Diagnostic Devices Market Sales, 2018-2023, 2024-2030, (K Pcs)
Global top five Next Generation Cancer Diagnostic Devices companies in 2022 (%)
The global Next Generation Cancer Diagnostic Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Next Generation Sequencing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Next Generation Cancer Diagnostic Devices include Roche Holding Ltd.?Switzerland), Abbott Laboratories(US), Siemens Healthcare(Germany), Agilent Technologies Inc(Germany), Illumina Inc.(US), Becton Dickinson and Co.(US), QIAGEN N.V.(Germany), Affymetrix Inc.(US) and Johnson & Johnson(US), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next Generation Cancer Diagnostic Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Cancer Diagnostic Devices Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Next Generation Cancer Diagnostic Devices Market Segment Percentages, by Type, 2022 (%)
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)
Global Next Generation Cancer Diagnostic Devices Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Next Generation Cancer Diagnostic Devices Market Segment Percentages, by Application, 2022 (%)
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Global Next Generation Cancer Diagnostic Devices Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Next Generation Cancer Diagnostic Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Cancer Diagnostic Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Next Generation Cancer Diagnostic Devices revenues share in global market, 2022 (%)
Key companies Next Generation Cancer Diagnostic Devices sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Next Generation Cancer Diagnostic Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Holding Ltd.?Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Cancer Diagnostic Devices, market overview.
Chapter 2: Global Next Generation Cancer Diagnostic Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Next Generation Cancer Diagnostic Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Cancer Diagnostic Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Next Generation Cancer Diagnostic Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Next Generation Cancer Diagnostic Devices Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Diagnostic Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Cancer Diagnostic Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Cancer Diagnostic Devices Overall Market Size
2.1 Global Next Generation Cancer Diagnostic Devices Market Size: 2022 VS 2030
2.2 Global Next Generation Cancer Diagnostic Devices Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Next Generation Cancer Diagnostic Devices Sales: 2018-2030
3 Company Landscape
3.1 Top Next Generation Cancer Diagnostic Devices Players in Global Market
3.2 Top Global Next Generation Cancer Diagnostic Devices Companies Ranked by Revenue
3.3 Global Next Generation Cancer Diagnostic Devices Revenue by Companies
3.4 Global Next Generation Cancer Diagnostic Devices Sales by Companies
3.5 Global Next Generation Cancer Diagnostic Devices Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Next Generation Cancer Diagnostic Devices Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Next Generation Cancer Diagnostic Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Players in Global Market
3.8.1 List of Global Tier 1 Next Generation Cancer Diagnostic Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Cancer Diagnostic Devices Market Size Markets, 2022 & 2030
4.1.2 Next Generation Sequencing
4.1.3 qPCR & Multiplexing
4.1.4 Lab-on- a- chip (LOAC)
4.1.5 Protein Microarrays
4.1.6 DNA Microarrays
4.1.7 Reverse Transcriptase-PCR (RT-PCR)
4.2 By Type - Global Next Generation Cancer Diagnostic Devices Revenue & Forecasts
4.2.1 By Type - Global Next Generation Cancer Diagnostic Devices Revenue, 2018-2023
4.2.2 By Type - Global Next Generation Cancer Diagnostic Devices Revenue, 2024-2030
4.2.3 By Type - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
4.3 By Type - Global Next Generation Cancer Diagnostic Devices Sales & Forecasts
4.3.1 By Type - Global Next Generation Cancer Diagnostic Devices Sales, 2018-2023
4.3.2 By Type - Global Next Generation Cancer Diagnostic Devices Sales, 2024-2030
4.3.3 By Type - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
4.4 By Type - Global Next Generation Cancer Diagnostic Devices Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Cancer Diagnostic Devices Market Size, 2022 & 2030
5.1.2 Biomarker Development
5.1.3 CTC Analysis
5.1.4 Proteomic Analysis
5.1.5 Epigenetic Analysis
5.1.6 Genetic Analysis
5.2 By Application - Global Next Generation Cancer Diagnostic Devices Revenue & Forecasts
5.2.1 By Application - Global Next Generation Cancer Diagnostic Devices Revenue, 2018-2023
5.2.2 By Application - Global Next Generation Cancer Diagnostic Devices Revenue, 2024-2030
5.2.3 By Application - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
5.3 By Application - Global Next Generation Cancer Diagnostic Devices Sales & Forecasts
5.3.1 By Application - Global Next Generation Cancer Diagnostic Devices Sales, 2018-2023
5.3.2 By Application - Global Next Generation Cancer Diagnostic Devices Sales, 2024-2030
5.3.3 By Application - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
5.4 By Application - Global Next Generation Cancer Diagnostic Devices Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Next Generation Cancer Diagnostic Devices Market Size, 2022 & 2030
6.2 By Region - Global Next Generation Cancer Diagnostic Devices Revenue & Forecasts
6.2.1 By Region - Global Next Generation Cancer Diagnostic Devices Revenue, 2018-2023
6.2.2 By Region - Global Next Generation Cancer Diagnostic Devices Revenue, 2024-2030
6.2.3 By Region - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
6.3 By Region - Global Next Generation Cancer Diagnostic Devices Sales & Forecasts
6.3.1 By Region - Global Next Generation Cancer Diagnostic Devices Sales, 2018-2023
6.3.2 By Region - Global Next Generation Cancer Diagnostic Devices Sales, 2024-2030
6.3.3 By Region - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Next Generation Cancer Diagnostic Devices Revenue, 2018-2030
6.4.2 By Country - North America Next Generation Cancer Diagnostic Devices Sales, 2018-2030
6.4.3 US Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.4.4 Canada Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.4.5 Mexico Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Next Generation Cancer Diagnostic Devices Revenue, 2018-2030
6.5.2 By Country - Europe Next Generation Cancer Diagnostic Devices Sales, 2018-2030
6.5.3 Germany Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5.4 France Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5.5 U.K. Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5.6 Italy Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5.7 Russia Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5.8 Nordic Countries Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.5.9 Benelux Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Next Generation Cancer Diagnostic Devices Revenue, 2018-2030
6.6.2 By Region - Asia Next Generation Cancer Diagnostic Devices Sales, 2018-2030
6.6.3 China Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.6.4 Japan Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.6.5 South Korea Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.6.6 Southeast Asia Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.6.7 India Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Next Generation Cancer Diagnostic Devices Revenue, 2018-2030
6.7.2 By Country - South America Next Generation Cancer Diagnostic Devices Sales, 2018-2030
6.7.3 Brazil Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.7.4 Argentina Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Sales, 2018-2030
6.8.3 Turkey Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.8.4 Israel Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.8.5 Saudi Arabia Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
6.8.6 UAE Next Generation Cancer Diagnostic Devices Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Roche Holding Ltd.?Switzerland)
7.1.1 Roche Holding Ltd.?Switzerland) Company Summary
7.1.2 Roche Holding Ltd.?Switzerland) Business Overview
7.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.1.4 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.1.5 Roche Holding Ltd.?Switzerland) Key News & Latest Developments
7.2 Abbott Laboratories(US)
7.2.1 Abbott Laboratories(US) Company Summary
7.2.2 Abbott Laboratories(US) Business Overview
7.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Laboratories(US) Key News & Latest Developments
7.3 Siemens Healthcare(Germany)
7.3.1 Siemens Healthcare(Germany) Company Summary
7.3.2 Siemens Healthcare(Germany) Business Overview
7.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.3.5 Siemens Healthcare(Germany) Key News & Latest Developments
7.4 Agilent Technologies Inc(Germany)
7.4.1 Agilent Technologies Inc(Germany) Company Summary
7.4.2 Agilent Technologies Inc(Germany) Business Overview
7.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.4.5 Agilent Technologies Inc(Germany) Key News & Latest Developments
7.5 Illumina Inc.(US)
7.5.1 Illumina Inc.(US) Company Summary
7.5.2 Illumina Inc.(US) Business Overview
7.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.5.5 Illumina Inc.(US) Key News & Latest Developments
7.6 Becton Dickinson and Co.(US)
7.6.1 Becton Dickinson and Co.(US) Company Summary
7.6.2 Becton Dickinson and Co.(US) Business Overview
7.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.6.5 Becton Dickinson and Co.(US) Key News & Latest Developments
7.7 QIAGEN N.V.(Germany)
7.7.1 QIAGEN N.V.(Germany) Company Summary
7.7.2 QIAGEN N.V.(Germany) Business Overview
7.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.7.5 QIAGEN N.V.(Germany) Key News & Latest Developments
7.8 Affymetrix Inc.(US)
7.8.1 Affymetrix Inc.(US) Company Summary
7.8.2 Affymetrix Inc.(US) Business Overview
7.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.8.5 Affymetrix Inc.(US) Key News & Latest Developments
7.9 Johnson & Johnson(US)
7.9.1 Johnson & Johnson(US) Company Summary
7.9.2 Johnson & Johnson(US) Business Overview
7.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson(US) Key News & Latest Developments
7.10 Thermo Fisher Scientific Inc.(US)
7.10.1 Thermo Fisher Scientific Inc.(US) Company Summary
7.10.2 Thermo Fisher Scientific Inc.(US) Business Overview
7.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.10.5 Thermo Fisher Scientific Inc.(US) Key News & Latest Developments
7.11 GE Healthcare(England)
7.11.1 GE Healthcare(England) Company Summary
7.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Business Overview
7.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.11.5 GE Healthcare(England) Key News & Latest Developments
7.12 Life Technologies Corp.(US)
7.12.1 Life Technologies Corp.(US) Company Summary
7.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Business Overview
7.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.12.5 Life Technologies Corp.(US) Key News & Latest Developments
7.13 Luminex Corp.(US)
7.13.1 Luminex Corp.(US) Company Summary
7.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Business Overview
7.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.13.5 Luminex Corp.(US) Key News & Latest Developments
7.14 Cepheid Inc.(US)
7.14.1 Cepheid Inc.(US) Company Summary
7.14.2 Cepheid Inc.(US) Business Overview
7.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.14.5 Cepheid Inc.(US) Key News & Latest Developments
7.15 Allegro Diagnostics Corp.(Brazil)
7.15.1 Allegro Diagnostics Corp.(Brazil) Company Summary
7.15.2 Allegro Diagnostics Corp.(Brazil) Business Overview
7.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2018-2023)
7.15.5 Allegro Diagnostics Corp.(Brazil) Key News & Latest Developments
8 Global Next Generation Cancer Diagnostic Devices Production Capacity, Analysis
8.1 Global Next Generation Cancer Diagnostic Devices Production Capacity, 2018-2030
8.2 Next Generation Cancer Diagnostic Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Next Generation Cancer Diagnostic Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Next Generation Cancer Diagnostic Devices Supply Chain Analysis
10.1 Next Generation Cancer Diagnostic Devices Industry Value Chain
10.2 Next Generation Cancer Diagnostic Devices Upstream Market
10.3 Next Generation Cancer Diagnostic Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Next Generation Cancer Diagnostic Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Next Generation Cancer Diagnostic Devices in Global Market
Table 2. Top Next Generation Cancer Diagnostic Devices Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Next Generation Cancer Diagnostic Devices Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Next Generation Cancer Diagnostic Devices Revenue Share by Companies, 2018-2023
Table 5. Global Next Generation Cancer Diagnostic Devices Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Next Generation Cancer Diagnostic Devices Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Next Generation Cancer Diagnostic Devices Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 9. List of Global Tier 1 Next Generation Cancer Diagnostic Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2018-2023
Table 15. By Type - Global Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2018-2023
Table 20. By Application - Global Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Next Generation Cancer Diagnostic Devices Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2018-2023
Table 25. By Region - Global Next Generation Cancer Diagnostic Devices Sales (K Pcs), 2024-2030
Table 26. By Country - North America Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Sales, (K Pcs), 2024-2030
Table 46. Roche Holding Ltd.?Switzerland) Company Summary
Table 47. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product Offerings
Table 48. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Roche Holding Ltd.?Switzerland) Key News & Latest Developments
Table 50. Abbott Laboratories(US) Company Summary
Table 51. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 52. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Abbott Laboratories(US) Key News & Latest Developments
Table 54. Siemens Healthcare(Germany) Company Summary
Table 55. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Offerings
Table 56. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Siemens Healthcare(Germany) Key News & Latest Developments
Table 58. Agilent Technologies Inc(Germany) Company Summary
Table 59. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Offerings
Table 60. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Agilent Technologies Inc(Germany) Key News & Latest Developments
Table 62. Illumina Inc.(US) Company Summary
Table 63. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 64. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Illumina Inc.(US) Key News & Latest Developments
Table 66. Becton Dickinson and Co.(US) Company Summary
Table 67. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 68. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Becton Dickinson and Co.(US) Key News & Latest Developments
Table 70. QIAGEN N.V.(Germany) Company Summary
Table 71. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Offerings
Table 72. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. QIAGEN N.V.(Germany) Key News & Latest Developments
Table 74. Affymetrix Inc.(US) Company Summary
Table 75. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 76. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Affymetrix Inc.(US) Key News & Latest Developments
Table 78. Johnson & Johnson(US) Company Summary
Table 79. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 80. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Johnson & Johnson(US) Key News & Latest Developments
Table 82. Thermo Fisher Scientific Inc.(US) Company Summary
Table 83. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 84. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Thermo Fisher Scientific Inc.(US) Key News & Latest Developments
Table 86. GE Healthcare(England) Company Summary
Table 87. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Offerings
Table 88. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. GE Healthcare(England) Key News & Latest Developments
Table 90. Life Technologies Corp.(US) Company Summary
Table 91. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 92. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Life Technologies Corp.(US) Key News & Latest Developments
Table 94. Luminex Corp.(US) Company Summary
Table 95. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 96. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Luminex Corp.(US) Key News & Latest Developments
Table 98. Cepheid Inc.(US) Company Summary
Table 99. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Offerings
Table 100. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Cepheid Inc.(US) Key News & Latest Developments
Table 102. Allegro Diagnostics Corp.(Brazil) Company Summary
Table 103. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Offerings
Table 104. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Allegro Diagnostics Corp.(Brazil) Key News & Latest Developments
Table 106. Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 107. Global Next Generation Cancer Diagnostic Devices Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Next Generation Cancer Diagnostic Devices Production by Region, 2018-2023 (K Pcs)
Table 109. Global Next Generation Cancer Diagnostic Devices Production by Region, 2024-2030 (K Pcs)
Table 110. Next Generation Cancer Diagnostic Devices Market Opportunities & Trends in Global Market
Table 111. Next Generation Cancer Diagnostic Devices Market Drivers in Global Market
Table 112. Next Generation Cancer Diagnostic Devices Market Restraints in Global Market
Table 113. Next Generation Cancer Diagnostic Devices Raw Materials
Table 114. Next Generation Cancer Diagnostic Devices Raw Materials Suppliers in Global Market
Table 115. Typical Next Generation Cancer Diagnostic Devices Downstream
Table 116. Next Generation Cancer Diagnostic Devices Downstream Clients in Global Market
Table 117. Next Generation Cancer Diagnostic Devices Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Segment by Type in 2022
Figure 2. Next Generation Cancer Diagnostic Devices Segment by Application in 2022
Figure 3. Global Next Generation Cancer Diagnostic Devices Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Next Generation Cancer Diagnostic Devices Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Next Generation Cancer Diagnostic Devices Revenue, 2018-2030 (US$, Mn)
Figure 7. Next Generation Cancer Diagnostic Devices Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Next Generation Cancer Diagnostic Devices Revenue in 2022
Figure 9. By Type - Global Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 11. By Type - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 12. By Type - Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 15. By Application - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 16. By Application - Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 20. By Region - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 21. By Country - North America Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 22. By Country - North America Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 23. US Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 28. Germany Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 29. France Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 37. China Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 41. India Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 43. By Country - South America Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 44. Brazil Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share, 2018-2030
Figure 48. Turkey Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Next Generation Cancer Diagnostic Devices Revenue, (US$, Mn), 2018-2030
Figure 52. Global Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Next Generation Cancer Diagnostic Devices by Region, 2022 VS 2030
Figure 54. Next Generation Cancer Diagnostic Devices Industry Value Chain
Figure 55. Marketing Channels
